Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Hanley MJ"'
Autor:
Hanley, MJ
Using grounded theory methodology this study retrospectively explored the social context of choking for at-risk adults and their carers through the lens of Australian coronial reports from 2000 - 2010. The data were the police, autopsy, finding, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bad9e87e20df1ce9989e5fb848e633b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael J. Hanley, Manolo D'Arcangelo, Enriqueta Felip, Pilar Garrido, Jiaxi Zhu, Meng Ye, Florin Vranceanu, Neeraj Gupta
Publikováno v:
Scientia
Anaplastic lymphoma kinase; Brigatinib; Drug-drug interaction Quinasa del linfoma anaplásico; Brigatinib; Interacción fármaco-fármaco Quinasa del limfoma anaplàstic; Brigatinib; Interacció medicament-medicament Brigatinib is a next-generation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f10869bd60746c4f94734d9ca837db
https://hdl.handle.net/11351/9443
https://hdl.handle.net/11351/9443
Autor:
Dick R (AUTHOR), Ferrara MS (AUTHOR), Agel J (AUTHOR), Courson R (AUTHOR), Marshall SW (AUTHOR), Hanley MJ (AUTHOR), Reifsteck F (AUTHOR)
Publikováno v:
Journal of Athletic Training (National Athletic Trainers' Association). Apr-Jun2007, Vol. 42 Issue 2, p221-233. 13p.
Autor:
Hanley MJ; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc, Lexington, MA, USA. Michael.Hanley@takeda.com., Zhang S; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc, Lexington, MA, USA., Griffin R; Global DMPK, Takeda Development Center Americas, Inc, Lexington, MA, USA., Zhu SX; Global DMPK, Takeda Development Center Americas, Inc, Lexington, MA, USA., Fram RJ; Clinical Science, Takeda Development Center Americas, Inc, Lexington, MA, USA., Lin J; Statistical & Quantitative Sciences, Takeda Development Center Americas, Inc, Lexington, MA, USA., Venkatakrishnan K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA., Gupta N; Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc, Lexington, MA, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2024 Aug; Vol. 42 (4), pp. 343-352. Date of Electronic Publication: 2024 May 24.
Autor:
Hanley MJ; Clinical Pharmacology, Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA., Yeo KR; Simcyp Division, Certara UK Limited, Sheffield, South Yorkshire, UK., Tugnait M; Clinical Pharmacology, Cerevel Therapeutics, Cambridge, Massachusetts, USA., Iwasaki S; Global DMPK, Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA., Narasimhan N; DMPK & Preclinical Safety, Theseus Pharmaceuticals, Cambridge, Massachusetts, USA., Zhang P; Clinical Science, Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA., Venkatakrishnan K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA., Gupta N; Clinical Pharmacology, Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Apr; Vol. 13 (4), pp. 624-637. Date of Electronic Publication: 2024 Jan 30.
Autor:
Hanley MJ; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA., Camidge DR; University of Colorado Cancer Center, Denver, Colorado, USA., Fram RJ; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA., Gupta N; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13766.
Autor:
Gupta N; Takeda Development Center Americas, Inc., Lexington, MA, USA. Neeraj.Gupta@takeda.com.; Takeda Development Centers America, Inc., 40 Landsdowne Street, MA, 02139, Cambridge, USA. Neeraj.Gupta@takeda.com., Hanley MJ; Takeda Development Center Americas, Inc., Lexington, MA, USA., Griffin RJ; Takeda Development Center Americas, Inc., Lexington, MA, USA., Zhang P; Takeda Development Center Americas, Inc., Lexington, MA, USA., Venkatakrishnan K; Millennium Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, 40 Landsdowne Street, MA, 02139, Cambridge, USA.; EMD Serono Research and Development Institute, Inc., Billerica, MA, USA., Sinha V; Takeda Development Center Americas, Inc., Lexington, MA, USA.; Novartis Development Corporation, East Hanover, NJ, USA.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2023 Aug; Vol. 62 (8), pp. 1063-1079. Date of Electronic Publication: 2023 Jul 26.